![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print June 30, 2000
Hematopoiesis Section, GMBB, NHGRI, NIH, Bethesda, MD 20892
Corresponding Author: tedyaz{at}nhgri.nih.gov
In red blood cells ankyrin (ANK-1) provides the primary linkage between the erythrocyte membrane skeleton and the plasma membrane. We have previously demonstrated that a 271 bp 5? flanking region of the ANK-1 gene had promoter activity in erythroid, but not non-erythroid, cell lines. To determine whether the ankyrin promoter could direct erythroid specific expression in vivo, we analyzed transgenic mice containing the ankyrin promoter fused to the human A
J. Biol. Chem, 10.1074/jbc.M004043200
Submitted on May 11, 2000
Accepted on June 30, 2000
A Minimal Ankyrin Promoter Linked to a Human gamma-Globin Gene Demonstrates Erythroid Specific Copy Number Dependent Expression with Minimal Position or Enhancer Dependence in Transgenic Mice
-globin gene. Sixteen of 17 lines expressed the transgene in erythroid cells indicating nearly position independent expression. We also observed a significant correlation between the level of Ank/A
-globin mRNA and transgene copy number. The level of Ank/A
mRNA averaged 11% of mouse
-globin mRNA per gene copy at all developmental stages. The addition of the HS2 enhancer from the
-globin Locus Control Region to the Ank/A
-globin transgene resulted in Ank/A
-globin mRNA expression in embryonic and fetal erythroid cells in 6/8 lines but absent or dramatically reduced levels of Ank/A
-globin mRNA in adult erythroid cells in 8/8 transgenic lines. These data indicate that the minimal ankyrin promoter contains all sequences necessary and sufficient for erythroid specific, copy number dependent, position independent expression of the human A
-globin gene.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. Moi and M. Sadelain Towards the genetic treatment of {beta}-thalassemia: new disease models, new vectors, new cells Haematologica, March 1, 2008; 93(3): 325 - 330. [Full Text] [PDF] |
||||
![]() |
P. G. Gallagher, D. G. Nilson, C. Wong, J. L. Weisbein, L. J. Garrett-Beal, S. W. Eber, and D. M. Bodine A dinucleotide deletion in the ankyrin promoter alters gene expression, transcription initiation and TFIID complex formation in hereditary spherocytosis Hum. Mol. Genet., September 1, 2005; 14(17): 2501 - 2509. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Wong, J. Lin, B. G. Forget, D. M. Bodine, and P. G. Gallagher Sequences Downstream of the Erythroid Promoter Are Required for High Level Expression of the Human {alpha}-Spectrin Gene J. Biol. Chem., December 31, 2004; 279(53): 55024 - 55033. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xue, X. Chen, Y. Chang, and J. J. Bieker Regulatory elements of the EKLF gene that direct erythroid cell-specific expression during mammalian development Blood, June 1, 2004; 103(11): 4078 - 4083. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Frazar, J. L. Weisbein, S. M. Anderson, A. P. Cline, L. J. Garrett, G. Felsenfeld, P. G. Gallagher, and D. M. Bodine Variegated Expression from the Murine Band 3 (AE1) Promoter in Transgenic Mice Is Associated with mRNA Transcript Initiation at Upstream Start Sites and Can Be Suppressed by the Addition of the Chicken {beta}-Globin 5' HS4 Insulator Element Mol. Cell. Biol., July 15, 2003; 23(14): 4753 - 4763. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Boulanger, D. E. Sabatino, E. Y. Wong, A. P. Cline, L. J. Garrett, M. Garbarz, D. Dhermy, D. M. Bodine, and P. G. Gallagher Erythroid Expression of the Human alpha -Spectrin Gene Promoter Is Mediated by GATA-1- and NF-E2-binding Proteins J. Biol. Chem., October 25, 2002; 277(44): 41563 - 41570. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Emery, E. Yannaki, J. Tubb, T. Nishino, Q. Li, and G. Stamatoyannopoulos Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma -globin gene silencing in vivo Blood, August 28, 2002; 100(6): 2012 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Gallagher, D. E. Sabatino, D. S. Basseres, D. M. Nilson, C. Wong, A. P. Cline, L. J. Garrett, and D. M. Bodine Erythrocyte Ankyrin Promoter Mutations Associated with Recessive Hereditary Spherocytosis Cause Significant Abnormalities in Ankyrin Expression J. Biol. Chem., November 2, 2001; 276(45): 41683 - 41689. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Persons, E. R. Allay, D. E. Sabatino, P. Kelly, D. M. Bodine, and A. W. Nienhuis Functional requirements for phenotypic correction of murine {beta}-thalassemia: implications for human gene therapy Blood, May 15, 2001; 97(10): 3275 - 3282. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Sabatino, N. E. Seidel, G. J. Aviles-Mendoza, A. P. Cline, S. M. Anderson, P. G. Gallagher, and D. M. Bodine Long-term expression of gamma -globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma -globin gene fused to the ankyrin-1 promoter PNAS, November 2, 2000; (2000) 230453097. [Abstract] [Full Text] |
||||
![]() |
D. E. Sabatino, N. E. Seidel, G. J. Aviles-Mendoza, A. P. Cline, S. M. Anderson, P. G. Gallagher, and D. M. Bodine Long-term expression of gamma -globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma -globin gene fused to the ankyrin-1 promoter PNAS, November 21, 2000; 97(24): 13294 - 13299. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |